Life sciences

Tile for Not quite Reddy – lessons on strategy for generic launches in the life sciences sector
November 11, 2025

Not quite Reddy – lessons on strategy for generic lau...

The recent High Court decision in Dr Reddy's Laboratories (UK) Ltd v Boehringer Ingelheim International GmbH [2025] EWHC 2834 (Pat)...
Read more
Tile for Healthcare financing and reimbursement in the UK – Stevens & Bolton’s recent contribution to the International Bar Association
July 7, 2025

Healthcare financing and reimbursement in the UK – St...

We were delighted to participate in the International Bar Association (IBA) Healthcare and Life Sciences Law Committee 2025 survey on...
Read more
Tile for Continued acceleration in the use and regulation of AI in the UK life sciences industry
June 26, 2025

Continued acceleration in the use and regulation of AI ...

The expanding role of AI in life sciences AI-driven models are increasingly used by pharmaceutical and biotechnology companies to...
Read more
Tile for Counterfeit pharmaceuticals: innovative strategies for combatting global health threats in the UK
June 25, 2025

Counterfeit pharmaceuticals: innovative strategies for ...

The pharmaceutical industry is one of the UK’s leading industrial sectors, contributing around £15bn in gross value added (GVA) to the...
Read more
Tile for The future of arbitration for life sciences companies
May 16, 2025

The future of arbitration for life sciences companies...

Arbitration is an alternative to litigation before a national court as a means of resolving disputes. It involves a neutral third party...
Read more
Tile for Okipa v Bionome Technology - illustrating the dangers of joint IP ownership
December 10, 2024

Okipa v Bionome Technology - illustrating the dangers o...

At the start of an exciting new joint venture project, the energy and optimism of collaborators, coupled with an understandable drive to...
Read more
Tile for Construction projects for life sciences businesses: collaborative working and effective project management
December 4, 2024

Construction projects for life sciences businesses: col...

As the UK life sciences sector continues to grow, numerous projects ranging from purpose-built labs with intricate specifications,...
Read more
Tile for The heart attack gender gap: women remain under-represented in clinical research about heart disease
October 18, 2024

The heart attack gender gap: women remain under-represe...

According to the British Heart Foundation, a woman is 50% more likely than a man to receive the wrong initial diagnosis for a heart...
Read more
Tile for Employment law overhaul: what employers in the Life Sciences sector need to know
September 12, 2024

Employment law overhaul: what employers in the Life Sci...

The new government has set out its priorities for the new parliament, which include an Employment Rights Bill, described as the biggest...
Read more
Tile for New guidance from the MHRA on medical devices that use machine learning
July 12, 2024

New guidance from the MHRA on medical devices that use ...

Artificial Intelligence promises a range of practical applications to improve efficiencies within the medical sector; in particular, the...
Read more
Tile for UK MHRA's intention to accept medical devices approved by international regulators
June 27, 2024

UK MHRA's intention to accept medical devices approved ...

On 21 May 2024, the UK Medicines and Healthcare products Regulation Agency (MHRA) issued a statement of policy intent describing a...
Read more
Tile for What can life sciences companies do to ensure they toe the line when it comes to ESG?
June 20, 2024

What can life sciences companies do to ensure they toe ...

Over the past decade, the focus on ESG (Environment, Social and Governance) has intensified, particularly in the EU and the UK....
Read more